Following the concern about the COVID-19 Virus the Agilent Cell Analysis Meeting in Germantown, MD tomorrow is CHANGING to an online session. 

Challenges and Breakthroughs in Immunotherapy Research

Join us for our Agilent Cell Analysis Seminar featuring next generation solutions for immune and CAR T cell therapy research.

The next generation of immune cell therapies require a new generation of analysis tools

A safe, potent, and persistent immune cell product depends on developers mustering the full repertoire of immune cell function; activation, proliferation, cell fate, cytotoxic killing, immunomodulation, and memory. All of which must be accomplished in the ever-changing, suppressive, and toxic tumor microenvironment.

Agilent is dedicated to supporting these next-generation therapies, providing key technologies to enable high-efficiency gene editing and assessment of real-time cell function, phenotype, and fate. Used together, this tool bench provides the capability to measure and control immune cell function, thus enabling translational researchers and developers to achieve the necessary level of therapeutic potency and safety.

This online virtual event is free and registration is required. 


For questions, please contact Leena Paul, Cell Analysis Product Specialist. 



 

Date
Tuesday, March 10, 2020

Time:
1:00 - 4:30pm

Location
Online Virtual Event 
 

  Register now  

For Research Use Only. Not for use in diagnostic procedures.

©2020 Agilent Technologies